Tumorigenesis and the angiogenic switch

G Bergers, LE Benjamin - Nature reviews cancer, 2003 - nature.com
It has become evident that we cannot understand tumour growth without considering
components of the stromal microenvironment, such as the vasculature. At the same time, the …

Metastasis: a question of life or death

P Mehlen, A Puisieux - Nature reviews cancer, 2006 - nature.com
The metastatic process is highly inefficient—very few of the many cells that migrate from the
primary tumour successfully colonize distant sites. One proposed mechanism to explain this …

Exploiting the PI3K/AKT pathway for cancer drug discovery

BT Hennessy, DL Smith, PT Ram, Y Lu… - Nature reviews Drug …, 2005 - nature.com
Evolving studies with several different targeted therapeutic agents are demonstrating that
patients with genomic alterations of the target, including amplification, translocation and …

Cancer as an evolutionary and ecological process

LMF Merlo, JW Pepper, BJ Reid, CC Maley - Nature reviews cancer, 2006 - nature.com
Neoplasms are microcosms of evolution. Within a neoplasm, a mosaic of mutant cells
compete for space and resources, evade predation by the immune system and can even …

Therapeutic strategies for rheumatoid arthritis

JS Smolen, G Steiner - Nature reviews Drug discovery, 2003 - nature.com
Recent years have seen considerable advances in our understanding of both the clinical
and basic-research aspects of rheumatoid arthritis. Clinical progress has come from a better …

The TOR pathway: a target for cancer therapy

MA Bjornsti, PJ Houghton - Nature Reviews Cancer, 2004 - nature.com
Rapamycin, a macrocyclic lactone, is a highly specific inhibitor of the serine/threonine
protein kinase target of rapamycin (TOR). Although it is clear that TOR controls initiation of …

Cytochrome P450 pharmacogenetics and cancer

C Rodriguez-Antona, M Ingelman-Sundberg - Oncogene, 2006 - nature.com
The cytochromes P450 (CYPs) are key enzymes in cancer formation and cancer treatment.
They mediate the metabolic activation of numerous precarcinogens and participate in the …

Inhibitors of NF-κB signaling: 785 and counting

TD Gilmore, M Herscovitch - Oncogene, 2006 - nature.com
Nuclear factor kappa B (NF-κB) transcription factors regulate several important physiological
processes, including inflammation and immune responses, cell growth, apoptosis, and the …

IκB kinase complexes: gateways to NF-κB activation and transcription

C Scheidereit - Oncogene, 2006 - nature.com
Transcription factors of the NF-κB family regulate hundreds of genes in the context of
multiple important physiological and pathological processes. NF-κB activation depends on …

mTOR, translation initiation and cancer

Y Mamane, E Petroulakis, O LeBacquer, N Sonenberg - Oncogene, 2006 - nature.com
Control of mRNA translation plays a fundamental role in many aspects of cell metabolism. It
constitutes a critical step in the control of gene expression, and consequently cell growth …